|
Volumn 62, Issue 1, 2008, Pages 133-138
|
Treatment recommendations of chronic hepatitis B. Did the world escape us?;Zalecenia leczenia przewlekłych zapaleń watroby typu B. Czy świat nam uciekł?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADEFOVIR;
ADENINE;
ALPHA2A INTERFERON;
ANTIVIRUS AGENT;
DRUG DERIVATIVE;
ENTECAVIR;
GUANINE;
LAMIVUDINE;
MACROGOL DERIVATIVE;
PEGINTERFERON ALFA-2A;
PEGINTERFERON ALPHA2A;
PHOSPHONIC ACID DERIVATIVE;
DISEASE MANAGEMENT;
DRUG COMBINATION;
HEALTH CARE DELIVERY;
HEALTH CARE PLANNING;
HEPATITIS B;
HUMAN;
ORGANIZATION AND MANAGEMENT;
POLAND;
PUBLIC HEALTH;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TREATMENT OUTCOME;
ADENINE;
ANTIVIRAL AGENTS;
DISEASE MANAGEMENT;
DRUG THERAPY, COMBINATION;
GUANINE;
HEALTH PLANNING GUIDELINES;
HEALTH SERVICES ACCESSIBILITY;
HEPATITIS B, CHRONIC;
HUMANS;
INTERFERON ALFA-2A;
LAMIVUDINE;
NATIONAL HEALTH PROGRAMS;
PHOSPHONIC ACIDS;
POLAND;
POLYETHYLENE GLYCOLS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT OUTCOME;
|
EID: 45949105260
PISSN: 00332100
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (10)
|